Do you start a statin concurrently with icosapent ethyl for patients with moderate hypertriglyceridemia and high ASCVD risk, or do you prefer to start a statin alone and monitor triglyceride levels?
Moderate hypertriglyceridemia is defined here as a triglyceride level of 150-499 mg/dL.
Answer from: at Academic Institution
Statin therapy can lower TGs modestly (up to 20%) and are the first line therapy for ASCVD risk reduction. Therefore I usually initiate statin therapy first and reassess lipids prior to considering use of icosapent ethyl. Additionally IPE adds pill burden (need to take 4 g a day), so I prefer to wai...
Generally, I prefer to start one treatment at a time and so would usually start with the statin first while working on other secondary causes of hypertriglyceridemia. If follow up lipid panel shows persistent hypertriglyceridemia (in a high ASCVD risk patient), I would then consider adding icosapen...
Comments
at Ucsf Asian Heart And Vascular Center Especially some statins note variable benefit to T...
at The George Washington University Hospital 490s trigly pose risk of pancreatitis, and should ...